Sarcopenia News and Research

RSS

Existing drug mitigates muscle loss from GLP-1 medications

Millions of Americans are currently taking GLP-1 medications such as Ozempic or Wegovy for weight loss.

2 Jun 2026

Low protein intake linked to declining physical function with age

Researchers have found that consuming lower amounts of protein-rich foods may negatively affect physical functioning as people grow older, underscoring the vital function protein plays in preserving mobility and muscle strength in adulthood.

28 May 2026

Olive waste extract may help lower fat and improve muscle markers

A polyphenol-rich olive oil byproduct may enhance muscle health, reducing fat mass and improving antioxidant markers in adults with metabolic risk factors.

18 May 2026

Simple physical function tests may identify adults at mobility risk

Research reveals a predictive model for early mobility limitations, emphasizing the impact of the Mediterranean diet and muscle power on aging health.

15 May 2026

Research links muscle loss, weaker grip and slower walking pace to higher risk of stroke

Muscle loss, a weaker grip and a slower walking pace were associated with a higher risk of stroke in adults, according to new research published today in Stroke, the peer-reviewed scientific journal of the American Stroke Association, a division of the American Heart Association.

7 May 2026

Six genes found to connect pancreatic cancer with metabolic dysfunction

New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer cancer outcomes and pointing to future ways to predict recurrence and develop more targeted treatments.

6 May 2026

Exercise remains essential alongside GLP-1 obesity treatments

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in the Journal of the American Medical Association, or JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.

5 May 2026

GLP-1 weight loss is driven mainly by fat loss, not muscle loss

GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose tissue, while lean body mass losses were generally modest. The findings suggest these treatments can support higher-quality weight loss when paired with individualized care, nutrition, and resistance training.

27 Apr 2026

Yoga to help manage obesity-related heart and metabolic risks

The impact of yoga on heart health in obesity is modest, suggesting it as a complementary approach for improving metabolic outcomes in high BMI populations.

27 Apr 2026

New collaboration targets muscle loss treatments for space missions

The Center for Myokine Convergence Research at Korea University College of Medicine (Director: Professor Hyeon Soo Kim, Department of Anatomy, Korea University College of Medicine) has signed a memorandum of understanding (MOU) with MFC to jointly develop therapeutics for muscle loss in astronauts.

10 Apr 2026

Python blood compound could lead to new weight loss therapies

University of Colorado Boulder researchers have discovered an appetite-suppressing compound in python blood that helps the snakes consume enormous meals and go months without eating yet remain metabolically healthy.

19 Mar 2026

Study finds GLP-1 medicines cut fat while preserving muscle function

Researchers found that GLP-1 medicines caused weight loss mainly through fat reduction, with only modest decreases in absolute muscle mass and no disproportionate loss of muscle function. In mice, physical performance improved, while in a small 12-week human pilot trial, strength was preserved despite reduced thigh muscle size.

18 Mar 2026

Specific gut microbe may boost muscle strength and performance

A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal Gut.

10 Mar 2026

Can peanut butter improve mobility after 65?

Research indicates that peanut butter can enhance muscle power in older adults, but its impact on overall physical function and gait speed is limited.

27 Feb 2026

Daily peanut butter intake boosts muscle power in older adults

A clinical trial by researchers at Deakin University's Institute for Physical Activity and Nutrition (IPAN) in Melbourne, Australia, found that a daily serving of peanut butter significantly boosted muscle power in older adults.

24 Feb 2026

Moderate physical activity lowers risk of sarcopenic obesity in seniors

Older people who are physically active have a significantly lower risk of developing sarcopenic obesity - a combination of obesity and weak muscles.

24 Feb 2026

Intermittent calorie restriction proves as effective as daily calorie cuts for type 2 diabetes

A post-hoc analysis of two clinical trials compared continuous calorie restriction with early time-restricted eating in adults with type 2 diabetes and overweight or obesity over three months. Both approaches improved weight, body composition, and metabolic health, with no clear superiority except for lower dropout with intermittent restriction.

18 Feb 2026